Burcon NutraScience Corporation

TSX:BU.TO

0.165 (CAD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CAD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998
Revenue 0.1840.3640.1710.2590.0310.040.0490.0880.1060.1050.0950.0300000000000000
Cost of Revenue 0.703000.7860.8461.2181.7391.3631.6031.8330000000000000-0.091-0.020
Gross Profit -0.5190.3640.171-0.527-0.815-1.178-1.69-1.275-1.497-1.7270.0950.03000000000000.0910.020
Gross Profit Ratio -2.81411-2.039-26.177-29.315-34.485-14.518-14.067-16.391110000000000045,25619,7060
Reseach & Development Expenses 3.3594.1251.8460.4140.7221.6931.9362.2452.6542.5362.3942.1031.042.892.1012.0912.1581.6551.3021.4061.3311.9562.20.9310.2060
General & Administrative Expenses 3.6253.7334.1984.3692.9432.713.7413.5574.2384.0423.9543.5555.0570000000000000
Selling & Marketing Expenses -0.026000000000000.0040000000000000
SG&A 3.5993.7334.1984.3692.9432.713.7413.5574.2384.0423.9543.5555.0626.0554.6432.7962.1122.0681.6141.7921.3091.5311.2670.8610.2610
Other Expenses 0-4.3140.1140.3420.364000.0030.660.0030.0030.0030.0046.0554.6472.7992.1142.071.6161.7951.3131.5351.7371.4180.5050.012
Operating Expenses 6.9587.8887.5284.833.6654.4025.6775.8056.8926.5816.3485.6626.1028.9456.7484.8894.2723.7252.9183.2012.6443.4913.9372.350.7120.012
Operating Income -7.477-7.525-7.398-4.595-3.723-4.552-5.59-5.829-6.785-6.889-6.253-5.631-6.102-8.945-6.748-4.889-4.272-3.725-2.918-3.201-2.644-3.491-3.937-2.259-0.692-0.012
Operating Income Ratio -40.556-20.679-43.142-17.767-119.584-113.303-114.039-66.363-63.776-65.369-66.012-185.79700000000000-1,129,599.5-691,9020
Total Other Income Expenses Net 0.031-17.798-3.2234.302-0.5690.0070.0590.1240.062-0.1040.2910.0860.13900000000000.01200
Income Before Tax -7.446-25.364-10.258-0.617-4.633-4.777-5.623-5.776-6.57-6.579-5.962-5.546-5.9620000000000-2.24700
Income Before Tax Ratio -40.39-69.699-59.826-2.387-148.824-118.908-114.718-65.761-61.752-62.431-62.936-182.96600000000000-1,123,665.500
Income Tax Expense 0.0780.0570.027-1.3090.0190.3240.2710.225-0.3420.31-0.5900-0.139-0.088-0.078-0.229-0.179-0.061-0.048-0.048-0.052-0.067-0.195-0.0540.009
Net Income -7.446-25.364-10.258-0.617-4.633-4.777-5.623-5.776-6.57-6.579-5.962-5.546-5.962-8.806-6.66-4.811-4.042-3.547-2.857-3.153-2.596-3.439-3.87-2.065-0.638-0.009
Net Income Ratio -40.39-69.699-59.826-2.387-148.824-118.908-114.718-65.761-61.752-62.431-62.936-182.96600000000000-1,032,319-637,6390
EPS -0.061-0.23-0.095-0.006-0.059-0.11-0.15-0.095-0.11-0.12-0.11-0.11-0.12-0.18-0.14-0.11-0.095-0.089-0.077-0.1-0.094-0.14-0.18-0.11-0.057-0.001
EPS Diluted -0.061-0.23-0.095-0.006-0.059-0.11-0.15-0.095-0.11-0.12-0.11-0.11-0.12-0.18-0.14-0.11-0.095-0.089-0.077-0.1-0.094-0.14-0.17-0.11-0.057-0.001
EBITDA -6.774-16.253-10.882-6.104-4.014-4.36-5.269-5.525-6.847-5.482-6.253-5.088-6-8.767-6.584-4.719-4.078-3.49-2.668-2.907-2.232-3.021-3.136-1.714-0.448-0.012
EBITDA Ratio -36.742-44.661-63.463-23.602-128.911-108.516-107.503-62.901-64.361-52.016-66.012-167.86200000000000-856,833.5-448,0550